Clinical Trials Logo

Noncommunicable Diseases clinical trials

View clinical trials related to Noncommunicable Diseases.

Filter by:

NCT ID: NCT05122832 Completed - Clinical trials for Non-Communicable Chronic Diseases

Prevalence of NCD Risk Factors in Kazakhstan

Start date: October 23, 2021
Phase:
Study type: Observational

This is a cross-sectional study that aims to study the prevalence of risk factors of noncommunicable diseases in people aged 18 to 69 years using the standardized and adopted STEPS questionnaire in the Republic of Kazakhstan.

NCT ID: NCT05005130 Completed - HIV Clinical Trials

Task-shifted Adaptation of the WHO-PEN Intervention to Address Cardio-metabolic Complications in People Living With HIV in Zambia

TASKPEN
Start date: September 20, 2021
Phase: N/A
Study type: Interventional

This mixed-methods formative research study aims to adapt the WHO Package of Essential Noncommunicable Disease Interventions (WHO-PEN) approach for the Zambian public health system, and pilot test an adapted, streamlined, and task-shifted package of integrated HIV Noncommunicable Disease (NCD) services, collectively called "TASKPEN".

NCT ID: NCT04961073 Completed - Clinical trials for Non-communicable Diseases

Prevalence of Multiple Risk Behaviours and Its Association With Health Consequence

Start date: June 21, 2021
Phase:
Study type: Observational

Hong Kong is facing an increasing threat of non-communicable diseases (NCDs), which is compounded by population aging. In 2016, 25,771 registered deaths (approximately 55%) were attributed to NCDs. In addition, NCDs caused 104,600 potential years of life lost before 70 years of age. WHO has identified four major behavioral risk factors - tobacco use, harmful use of alcohol, an unhealthy diet, and physical inactivity - that contribute substantially to NCDs and can increase the risk of death. Most premature deaths from NCDs are preventable via lifestyle modification. Therefore, helping people adopting healthy lifestyle practices, such as having a balanced diet and engaging in irregular physical activity, and quitting health-risk behaviors, such as smoking and harmful use of alcohol can help prevent NCDs and improve the quality of life and overall health of the population. However, many people are unmotivated or find it difficult to modify their risk behaviors, despite their awareness of the associated health hazards.

NCT ID: NCT04820556 Completed - Asthma Clinical Trials

Gut Microbiota in Chronic Noncommunicable Diseases

Start date: April 12, 2021
Phase:
Study type: Observational

It is an observational study in patients with chronic noncommunicable diseases (i.e. cardiovascular diseases, diabetes mellitus, non-alcoholic fatty liver disease, chronic obstructive pulmonary disease and asthma ) and control group with no signs of these conditions. The study has a prospective part planned for 2021 and a retrospective part which includes the patients enrolled between 2018-2020. The aim of the study is to investigate gut microbiota composition, its metabolites, levels of inflammatory and other markers of the disease in prospective groups (arterial hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma, non-alcoholic fatty liver disease and control patients) as well as in retrospective groups (chronic heart failure with preserved and reduced ejection fraction, obstructive atherosclerosis of any vascular bed, arterial hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma, non-alcoholic fatty liver disease, and control patients). Also we are planning to investigate the association between gut microbiota composition and its metabolites, levels of inflammatory and other markers of the disease in retrospective and prospective groups.

NCT ID: NCT04513236 Completed - Clinical trials for Surveys and Questionnaires

Use of Airtime Timing to Improve Interactive Voice Response Surveys in Bangladesh and Uganda

Start date: March 26, 2017
Phase: N/A
Study type: Interventional

This study evaluates the effect of two different airtime incentive timings on interactive voice response (IVR) survey cooperation, response, refusal and contact rates, as compared to a control group, in Bangladesh and Uganda.

NCT ID: NCT04508010 Completed - Clinical trials for Surveys and Questionnaires

Comparison of IVR and CATI Surveys in Bangladesh

Start date: August 25, 2020
Phase: N/A
Study type: Interventional

This study focuses on mechanisms to adapt the performance of interactive voice response (IVR) and computer assisted telephone interviews (CATI) surveys conducted in low-and middle-income (LMIC) setting (Bangladesh) and evaluates how the two survey modalities (IVR and CATI) affect survey metrics, including response, completion and attrition rates.

NCT ID: NCT04506931 Completed - Clinical trials for Surveys and Questionnaires

Comparison of SMS, IVR, and CATI Surveys in Colombia

Start date: January 15, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to adapt and assess the feasibility, quality, and validity of short message service or 'text message' (SMS), interactive voice response (IVR), and computer assisted telephone interviews (CATI) for collecting information on noncommunicable disease (NCD) risk factors

NCT ID: NCT04506918 Completed - Clinical trials for Surveys and Questionnaires

Comparison of SMS and IVR Surveys in Tanzania

Start date: October 23, 2020
Phase: N/A
Study type: Interventional

This study focuses on mechanisms to adapt the performance of interactive voice response (IVR) and short message service (SMS) surveys conducted in low-and middle-income (LMIC) setting (Tanzania) and evaluates how the two survey modalities (IVR and SMS) affect survey metrics, including response, completion and attrition rates.

NCT ID: NCT04492384 Completed - Hypertension Clinical Trials

Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients

ACTIV
Start date: June 29, 2020
Phase:
Study type: Observational

Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in adults.

NCT ID: NCT04394520 Completed - Clinical trials for Surveys and Questionnaires

Use of Consent Language and Mode to Improve Interactive Voice Response Survey in Colombia and Uganda

Start date: August 31, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effect of one new form of introduction language and three new modes of providing consent on interactive voice response (IVR) survey cooperation, response, refusal and contact rates, as compared to control group, in Colombia and Uganda.